Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy

What will we expect from novel therapies for oesophageal and gastric malignancies?

Biomarkers of pembrolizumab response in head and neck cancer

Impact of microbiome on head and neck cancers

Editor’s Choice for March 2018

A Zimbabwean perspective on radiotherapy in care and training

The promise of immunotherapy for elderly patients

Treatments for elderly head and neck cancer patients

Editor's Choice for September 2017

Pembrolizumab falls short of endpoints in KEYNOTE 40

Durvalumab in novel combinations for head and neck cancer

Treatment choices in thyroid cancer